In the last trading session, 1.15 million shares of the Aldeyra Therapeutics Inc (NASDAQ:ALDX) were traded, and its beta was 0.68. Most recently the company’s share price was $3.02, and it changed around $0.24 or 8.63% from the last close, which brings the market valuation of the company to $180.88M. ALDX currently trades at a discount to its 52-week high of $7.20, offering almost -138.41% off that amount. The share price’s 52-week low was $1.14, which indicates that the current value has risen by an impressive 62.25% since then.
Aldeyra Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 6 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 0 recommended ALDX as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight.
Aldeyra Therapeutics Inc (NASDAQ:ALDX) trade information
Instantly ALDX has showed a green trend with a performance of 8.63% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 3.08 on recent trading dayincreased the stock’s daily price by 1.95%. The company’s shares are currently down -39.48% year-to-date, but still up 13.11% over the last five days. On the other hand, Aldeyra Therapeutics Inc (NASDAQ:ALDX) is 39.81% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $11, which translates to bulls needing to increase their stock price by 72.55% from its current value. Analyst projections state that ALDX is forecast to be at a low of $10 and a high of $12.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 15.99%. Aldeyra Therapeutics Inc earnings are expected to increase by -2.98% in 2025, but the outlook is positive 42.10% per year for the next five years.
ALDX Dividends
Aldeyra Therapeutics Inc’s next quarterly earnings report is expected to be released in July.
KNOLL CAPITAL MANAGEMENT, LLC, with 9.2158% or 5.48 million shares worth $18.12 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
